Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms

Interferon Alpha Therapy Increases Pro-Thrombotic Biomarkers in Patients with Myeloproliferative Neoplasms

Myeloproliferative neoplasms (MPN) are associated with an increased risk of arterial and venous thrombosis. Pegylated-interferon alpha (IFN) and hydroxyurea (HU) are commonly used to treat MPN, but their effect on hemostasis has not yet been studied. The aim of our study was to determine whether IFN...

Full description

Bibliographic Details
Main Authors: Dorothée Faille, Lamia Lamrani, Stéphane Loyau, Marie-Geneviève Huisse, Marie-Charlotte Bourrienne, Sawsaneh Alkhaier, Bruno Cassinat, Yacine Boulaftali, Jérôme Debus, Martine Jandrot-Perrus, Christine Chomienne, Christine Dosquet, Nadine Ajzenberg
Format: Article
Language:English
Published: MDPI AG 2020-04-01
Series:Cancers
Subjects:
myeloproliferative neoplasms
interferon
prothrombotic markers
Online Access:https://www.mdpi.com/2072-6694/12/4/992

Internet

https://www.mdpi.com/2072-6694/12/4/992

Similar Items